Related references
Note: Only part of the references are listed.A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks
Debby den Uyl et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
Kim Horslev-Petersen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review
Helga Radner et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice
D. De Cock et al.
CLINICAL RHEUMATOLOGY (2014)
Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis
S. Meyfroidt et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)
Marjatta Leirisalo-Repo et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
P. H. de Jong et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Validation of the Methotrexate-First Strategy in Patients With Early, Poor-Prognosis Rheumatoid Arthritis: Results From a Two-Year Randomized, Double-Blind Trial
James R. O'Dell et al.
ARTHRITIS AND RHEUMATISM (2013)
Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort
Bernard Combe et al.
JOURNAL OF RHEUMATOLOGY (2013)
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis A Randomized Trial
Marije F. Bakker et al.
ANNALS OF INTERNAL MEDICINE (2012)
A Randomized Comparative Effectiveness Study of Oral Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis The Treatment of Early Aggressive Rheumatoid Arthritis Trial
Larry W. Moreland et al.
ARTHRITIS AND RHEUMATISM (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Glucocorticoids
Cornelia M. Spies et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
Optimal care for early RA patients: the challenge of translating scientific data into clinical practice
Patrick Verschueren et al.
RHEUMATOLOGY (2011)
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis
Lilian H. D. van Tuyl et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
Y. P. M. Goekoop-Ruiterman et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
S. L. Gorter et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Similar Effects of Disease-Modifying Antirheumatic Drugs, Glucocorticoids, and Biologic Agents on Radiographic Progression in Rheumatoid Arthritis Meta-Analysis of 70 Randomized Placebo-Controlled or Drug-Controlled Studies, Including 112 Comparisons
Niels Graudal et al.
ARTHRITIS AND RHEUMATISM (2010)
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis
Jos N. Hoes et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis
Margaret H. Y. Ma et al.
RHEUMATOLOGY (2010)
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
R. F. van Vollenhoven et al.
LANCET (2009)
Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study
P. Verschueren et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis
Greet Esselens et al.
MUSCULOSKELETAL CARE (2009)
Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis
L. H. D. van Tuyl et al.
RHEUMATOLOGY (2008)
Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis
P. Verschueren et al.
RHEUMATOLOGY (2008)
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2007)
Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
Lilian H. D. van Tuyl et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Comparison of treatment strategies in early rheumatoid arthritis - A randomized trial
Yvonne P. M. Goekoop-Ruiterman et al.
ANNALS OF INTERNAL MEDICINE (2007)
Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis - Results from a randomized placebo-controlled trial
G Haugeberg et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
C Grigor et al.
LANCET (2004)
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs -: Five-year experience from the FIN-RACo study
M Korpela et al.
ARTHRITIS AND RHEUMATISM (2004)
Glucocorticoids in the treatment of rheumatic diseases - An update on the mechanisms of action
F Buttgereit et al.
ARTHRITIS AND RHEUMATISM (2004)
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology
F Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications - Results of a two-year, randomized, double-blind, placebo-controlled trial
JR O'Dell et al.
ARTHRITIS AND RHEUMATISM (2002)
COBRA combination therapy in patients with early rheumatoid arthritis -: Long-term structural benefits of a brief intervention
RBM Landewé et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
